VR Therapy for Bone Marrow Transplant
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment BMT-VR for patients undergoing bone marrow transplant?
Research shows that virtual reality (VR) can help reduce symptoms like anxiety, depression, and pain in patients undergoing treatments similar to bone marrow transplants. VR has also been effective in improving quality of life and managing symptoms in cancer patients, suggesting it could be beneficial for those undergoing bone marrow transplants.12345
How is the BMT-VR treatment different from other treatments for bone marrow transplant patients?
What is the purpose of this trial?
The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigned into one of the study groups: the virtual reality psychosocial intervention (BMT-VR) + usual care versus usual care alone.The BMT-VR intervention has several components:1. Psychoeducation to enhance preparedness, manage expectations, and mobilize social supports.2. Psychosocial skill building to promote effective coping and facilitate acceptance while living with uncertainty of treatment outcomes.3. Self-care to promote effective coping and enhance patient's sense of control as they transition from inpatient to outpatient care
Research Team
Areej El-Jawahri, MD
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for English-speaking adults over 18 with blood cancer, admitted for bone marrow transplantation (BMT). It's not suitable for those with benign blood conditions or acute psychiatric/cognitive issues that prevent informed consent or following the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the BMT-VR intervention during their BMT hospitalization, which includes six sections focused on education and coping strategies
Follow-up
Participants are monitored for quality of life and psychological outcomes through questionnaires at baseline, 2, 4, 12, and 24 weeks
Extension
Participants may continue to be monitored for long-term outcomes beyond the initial follow-up period
Treatment Details
Interventions
- BMT-VR
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor